The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Anti-inflammatory Activity of IVIG Mediated Through the Inhibitory Fc Receptor
Abstract
The molecular basis for the anti-inflammatory property of intravenous gamma globulin (IVIG) was investigated in a murine model of immune thrombocytopenia. Administration of clinically protective doses of intact antibody or monomeric Fc fragments to wild-type or Fcγ receptor–humanized mice prevented platelet consumption triggered by a pathogenic autoantibody. The inhibitory Fc receptor, FcγRIIB, was required for protection, because disruption either by genetic deletion or with a blocking monoclonal antibody reversed the therapeutic effect of IVIG. Protection was associated with the ability of IVIG administration to induce surface expression of FcγRIIB on splenic macrophages. Modulation of inhibitory signaling is thus a potent therapeutic strategy for attenuating autoantibody-triggered inflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
Clynes, R. A., Towers, T. L., Presta, L. G., & Ravetch, J. V. (2000) · Nature Medicine · doi:10.1038/74704 · Cited by 2,768
HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD
Imbach, P., d'APUZZO, V., Hirt, A., Rossi, E., Vest, M., Barandun, S., Baumgartner, C., Morell, A., Schöni, M., & Wagner, H. P. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92400-4 · Cited by 1,666
van der Meché, F. G. A., Schmitz, P. I. M., & the Dutch Guillain–Barré Study Group* (1992) · New England Journal of Medicine · doi:10.1056/nejm199204233261705 · Cited by 1,143
Dalakas, M. C., Illa, I., Dambrosia, J. M., Soueidan, S. A., Stein, D. P., Otero, C., Dinsmore, S. T., & McCrosky, S. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292704 · Cited by 1,136
Inhibition of Toxic Epidermal Necrolysis by Blockade of CD95 with Human Intravenous Immunoglobulin
Viard, I., Wehrli, P., Bullani, R., Schneider, P., Holler, N., Salomon, D., Hunziker, T., Saurat, J.-H., Tschopp, J., & French, L. E. (1998) · Science · doi:10.1126/science.282.5388.490 · Cited by 1,005
Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin
(1999) · Transfusion Medicine Reviews · doi:10.1016/s0887-7963(99)80071-6 · Cited by 869
Augmented humoral and anaphylactic responses in FcγRII-deficient mice
Takai, T., Ono, M., Hikida, M., Ohmori, H., & Ravetch, J. V. (1996) · Nature · doi:10.1038/379346a0 · Cited by 826
Self-citationOno, M., Bolland, S., Tempst, P., & Ravetch, J. V. (1996) · Nature · doi:10.1038/383263a0 · Cited by 781
Self-citationSpontaneous Autoimmune Disease in FcγRIIB-Deficient Mice Results from Strain-Specific Epistasis
Bolland, S., & Ravetch, J. V. (2000) · Immunity · doi:10.1016/s1074-7613(00)00027-3 · Cited by 752
Self-citationManipulating the Immune System with Immune Globulin
Oates, J. A., Wood, A. J. J., & Dwyer, J. M. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201093260206 · Cited by 648
Clynes, R., Maizes, J. S., Guinamard, R., Ono, M., Takai, T., & Ravetch, J. V. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.1.179 · Cited by 387
Self-citationSHIP Modulates Immune Receptor Responses by Regulating Membrane Association of Btk
Bolland, S., Pearse, R. N., Kurosaki, T., & Ravetch, J. V. (1998) · Immunity · doi:10.1016/s1074-7613(00)80555-5 · Cited by 384
Self-citationTreatment of Refractory Immune Thrombocytopenic Purpura with an Anti-Fcγ-Receptor Antibody
Clarkson, S. B., Bussel, J. B., Kimberly, R. P., Valinsky, J. E., Nachman, R. L., & Unkeless, J. C. (1986) · New England Journal of Medicine · doi:10.1056/nejm198605083141907 · Cited by 365
Infusion of Fcγ fragments for treatment of children with acute immune thrombocytopenic purpura
Debré, M., Griscelli, C., Bonnet, M.-C., Carosella, E., Philippe, N., Reinert, P., Vilmer, E., Kaplan, C., Fridman, W. H., & Teillaud, J.-L. (1993) · The Lancet · doi:10.1016/0140-6736(93)92000-j · Cited by 329
Blanchette, V. S., Adams, M., Wang, E., McMillan, J., Imbach, P. A., Andrew, M., MILNER, R. A., Ali, K., Barnard, D., Bernstein, M. L., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92205-5 · Cited by 325
Treatment of systemic vasculitis with pooled intravenous immunoglobulin
Jayne, D. R. W., Lockwood, C. M., Davies, M. J., Fox, C. J. V., & Black, C. M. (1991) · The Lancet · doi:10.1016/0140-6736(91)92797-6 · Cited by 297
Cytotoxic antibodies trigger inflammation through Fc receptors
Clynes, R., & Ravetch, J. V. (1995) · Immunity · doi:10.1016/1074-7613(95)90155-8 · Cited by 250
Self-citationNakamura, A., Yuasa, T., Ujike, A., Ono, M., Nukiwa, T., Ravetch, J. V., & Takai, T. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.5.899 · Cited by 208
Self-citationHIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR MYASTHENIA GRAVIS
Gajdos, P., Outin, H., Elkharrat, D., Brunel, D., de Rohan-Chabot, P., Raphael, J. C., Goulon, M., Goulon-Goeau, C., & Morel, E. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90469-0 · Cited by 195
Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory diseases
Ballow, M. (1997) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(97)70217-3 · Cited by 163
Reconstitution of human Fc gamma RIII cell type specificity in transgenic mice.
Li, M. Y., Wirthmueller, U., & Ravetch, J. V. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.3.1259 · Cited by 65
Self-citationSoubrane, C., Tourani, J. M., Andrieu, J., Visonneau, S., Beldjord, K., Israël‐Biet, D., Mouawad, R., Bussel, J. B., Weil, M., & Khayat, D. (1993) · Blood · doi:10.1182/blood.v81.1.15.15 · Cited by 54
Cited by
Fcγ receptors as regulators of immune responses
Nimmerjahn, F., & Ravetch, J. V. (2008) · Nature Reviews Immunology · doi:10.1038/nri2206 · Cited by 2,947
Self-citationFcRn: the neonatal Fc receptor comes of age
Roopenian, D. C., & Akilesh, S. (2007) · Nature Reviews Immunology · doi:10.1038/nri2155 · Cited by 2,346
Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation
Kaneko, Y., Nimmerjahn, F., & Ravetch, J. V. (2006) · Science · doi:10.1126/science.1129594 · Cited by 1,754
Self-citationLock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E., Garren, H., Langer-Gould, A., Strober, S., Cannella, B., Allard, J., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-500 · Cited by 1,669
Immunomodulation of Autoimmune and Inflammatory Diseases with Intravenous Immune Globulin
Kazatchkine, M. D., & Kaveri, S. V. (2001) · New England Journal of Medicine · doi:10.1056/nejmra993360 · Cited by 1,209
Metadata
- Authors
- Samuelsson, A., Towers, T. L., & Ravetch, J. V.
- Venue
- Science
- Published
- 2001-01-19
- Volume
- 291
- Issue
- 5503
- Pages
- 484-486
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1964180982
- Cited by
- 1,053
- References
- 22
- FWCI
- 50.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.